| zonisamide / Generic mfg. |
NCT00650052: Fasting Study of Zonisamide Capsules 100 mg and Zonegran® Capsules 100 mg |
|
|
| Completed | 1 | 107 | US | Zonisamide Capsules 100 mg, Zonegran® Capsules 100 mg | Mylan Pharmaceuticals Inc | Healthy | 12/03 | 12/03 | | |
NCT00649714: Fed Study of Zonisamide Capsules 100 mg and Zonegran® Capsules 100 mg |
|
|
| Completed | 1 | 110 | US | Zonisamide Capsules 100 mg, Zonegran® Capsules 100 mg | Mylan Pharmaceuticals Inc | Healthy | 01/04 | 01/04 | | |
NCT01161966: Bioequivalence Study of Zonisamide Capsules 100 mg of Dr.Reddy's Laboratories Limited Under Fasting Conditions |
|
|
| Completed | 1 | 26 | US | Zonisamide, Zonegran Capsules 100 mg, Zonegran | Dr. Reddy's Laboratories Limited | Healthy | 02/05 | 03/05 | | |
NCT01161979: Bioequivalence Study of Zonisamide Capsules 100 mg of Dr.Reddy's Laboratories Limited Under Fed Conditions |
|
|
| Completed | 1 | 26 | US | Zonisamide, Zonegran Capsules 100 mg, Zonegran | Dr. Reddy's Laboratories Limited | Healthy | 02/05 | 03/05 | | |
NCT00685139: Fasting Bioavailability Study of Zonisamide Capsules |
|
|
| Completed | 1 | 34 | US | Zonisamide 100 mg Capsule, Zonisamide (Zonegran®) 100 mg Capsule, Zonegran® | Mutual Pharmaceutical Company, Inc. | Healthy | 03/05 | 03/05 | | |
NCT00687167: Fed Bioavailability Study of Zonisamide Capsules |
|
|
| Completed | 1 | 34 | US | Zonisamide 100 mg Capsule, Zonisamide (Zonegran®) 100 mg Capsule, Zonegran® | Mutual Pharmaceutical Company, Inc. | Healthy | 03/05 | 03/05 | | |
| Completed | 1 | 21 | US | Oxcarbazepine (brand name vs generic drugs), Divalproex Sodium (brand name vs generic drugs), Carbamazepine (brand name vs generic drugs), Lamotrigine (brand name vs generic drugs), levetiracetam (brand name vs generic drugs), Topiramate (brand name vs generic drugs), Zonisamide (brand name vs generic drugs), Phenytoin sodium (brand name vs generic drugs) | Food and Drug Administration (FDA), University of Maryland, Baltimore | Epilepsy | 08/18 | 09/18 | | |
